Prevention of liver fibrosis and cancer in africa: The PROLIFICA project - A collaborative study of hepatitis b-related liver disease in West Africa

South African Medical Journal

Volumn 105, Issue 3, 2015, Pages 185-186

  Howell, Jessica ^a,b,c   Ladep, Nimzing G ^a,d   Lemoine, Maud ^a,e   Nayagam, Shevanthi ^a   Toure, Papa Souleymane ^f   Diop, Magatte Madoky ^f   Daveiga, Joao Armindo ^f   Sall, Amina Sow ^g   Lo, Gora ^g   Crossey, Mary M E ^a   Thursz, Mark R ^a   Taylor Robinson, Simon D ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b BURNET INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF JOS   (Nigeria)

^e Medical Research Council (The Gambia Unit)   (South Africa)

^f UFR Santé Thiès University   (South Africa)

^g Laboratoire de Bacteriologie Virologie Le Dantec Hospital   (South Africa)

Author keywords

Epidemiology; Hepatocellular carcinoma; Viral hepatitis

Indexed keywords

ACHIEVEMENT; AFRICA SOUTH OF THE SAHARA; CANCER SCREENING; DISEASE SEVERITY; EDITORIAL; ELASTOGRAPH; HEALTH CARE; HEALTH EDUCATION; HEPATITIS B; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER FIBROSIS; MEDICAL RESEARCH; PROPHYLAXIS; PUBLIC HEALTH; AFRICA; CARCINOMA, HEPATOCELLULAR; COMPLICATION; COOPERATION; LIVER CIRRHOSIS; LIVER NEOPLASMS; VIROLOGY;

AFRICA, WESTERN; CARCINOMA, HEPATOCELLULAR; COOPERATIVE BEHAVIOR; HEPATITIS B; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS;

EID: 84923789055     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/samj.8880     Document Type: Editorial

References (14)

1. European Association for the Study of the Liver. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol 2012;57(1):167-185. [http://dx.doi.org/10.1016/j. jhep.2012.02.010]
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55(2):74-108. [http://dx.doi.org/10.3322/canjclin.55.2.74]
3. Parkin DM, Sitas F, Chirenje M, Stein L, Abratt R, Wabinga H. Part I: Cancer in indigenous Africans–burden, distribution, and trends. Lancet Oncol 2008;9(7):683-692. [http://dx.doi.org/10.1016/S1470-2045(08)70175-X]
4. Kirk GD, Lesi OA, Mendy M, et al. The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology 2004;39(1):211-219. [http://dx.doi.org/10.1002/hep.20027]
5. European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma. J Hepatol 2012;56(4):908-943. [http://dx.doi.org/10.1016/j.jhep.2011.12.001]
6. Robotin MC, Kansil MQ, George J, et al. Using a population-based approach to prevent hepatocellular cancer in New South Wales, Australia: Effects on health services utilisation. BMC Health Serv Res 2010;10:215. [http://dx.doi.org/10.1186/1472-6963-10-215]
7. Liaw YF, Sung JJ, Chow WC, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 2004;351(15):1521-1531. [http://dx.doi.org/10.1056/NEJMoa033364]
8. Lopez PM, Villanueva A, Llovet JM. Systematic review: Evidence-based management of hepatocellular carcinoma–an updated analysis of randomized controlled trials. Aliment Pharmacol Ther 2006;23(11):1535-1547. [http://dx.doi.org/10.1111/j.1365-2036.2006.02932.x]
9. World Health Organization.Global policy report on the prevention and control of viral hepatitis in WHO Member States. http://www.who.int/csr/disease/hepatitis/global_report/en/ (accessed 21 April 2014).
10. European Union Framework 7. www.prolifica.eu (accessed August 2014).
11. Shariff MI, Ladep NG, Cox IJ, et al. Characterization of urinary biomarkers of hepatocellular carcinoma using magnetic resonance spectroscopy in a Nigerian population. J Proteome Res 2010;9(2):1096-1103. [http://dx.doi.org/10.1021/pr901058t]
12. Ladep NG, Dona AC, Lewis MR, et al. Discovery and validation of urinary metabotypes for the diagnosis of hepatocellular carcinoma (HCC) in West Africans. Hepatology 2014;60(4):1291-301. [http://dx.doi.org/10.1002/hep.27264]
13. Shimakawa Y, Yan HJ, Tsuchiya N, Bottomley C, Hall AJ. Association of early age at establishment of chronic hepatitis B infection with persistent viral replication, liver cirrhosis and hepatocellular carcinoma: A systematic review. PLoS One 2013;8(7):e69430. [http://dx.doi.org/10.1371/journal. pone.0069430]
14. Lemoine M, Shimakawa Y, Njie R, et al. Food intake increases liver stiffness measurements and hampers reliable values in patients with chronic hepatitis B and healthy controls: The PROLIFICA experience in The Gambia. Aliment Pharmacol Ther 2014;39(2):188-96. [http://dx.doi.org/10.1111/apt.12561]